Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Demonstrating advanced practice provider value: Implementing a new advanced practice provider billing algorithm.
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10?854 patients from the CHAMPION PHOENIX trial.
Respiratory Mucosa
Hemorheology
CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.
CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo. J Invest Dermatol. 2015 Jun; 135(6):1574-1580.
View in:
PubMed
subject areas
Animals
Autoimmunity
Biolistics
Cell Membrane
Cell Proliferation
Chemokine CCL22
DNA
Flow Cytometry
Humans
Hypopigmentation
Melanocytes
Mice
Mice, Inbred C57BL
Mice, Transgenic
Monophenol Monooxygenase
Pigmentation
Skin
Spleen
T-Lymphocytes, Regulatory
Transgenes
Vitiligo
authors with profiles
Shikhar Mehrotra